Literature DB >> 8594213

Neurotrophic factors in central nervous system trauma.

I Mocchetti1, J R Wrathall.   

Abstract

Although regeneration of injured neurons does not occur after trauma in the central nervous system (CNS), there is often significant recovery of functional capacity with time. Little is currently known about the molecular basis for such recovery, but the increased trophic activity in injured CNS tissue and the known properties of neurotrophic factors in neuronal growth and maintenance suggest that these polypeptides are probably involved in recovery of function. Members of the neurotrophin family, including nerve growth factor (NGF), brain-derived neurotrophic factors (BDNF), and neurotrophin 3 (NT-3), are capable of supporting survival of injured CNS neurons both in vitro and in vivo. They also stimulate neurite outgrowth, needed for reorganization of the injured CNS, and the expression of key enzymes for neurotransmitter synthesis that may need to be upregulated to compensate for reduced innervation. The effects of the neurotrophins are mediated through specific high affinity trk receptors (trk A, B, C) as well as a common low affinity receptor designated p75NGFR. Another class of neurotrophic polypeptides also provides candidate recovery-promoting molecules, the heparin-binding growth factors' acidic and basic fibroblast growth factor (aFGF, bFGF). FGFs not only sustain survival of injured neurons but also stimulate revascularization and certain glial responses to injury. Both the neurotrophins and the FGFs, as well as their respective receptors, have been shown to be upregulated after experimental CNS injury. Further, administration of neurotrophins or FGF has been shown to reduce the effects of experimental injury induced by axotomy, excitotoxins, and certain other neurotoxins. The cellular basis for the potential therapeutic use of neurotrophic molecules is discussed as well as new strategies to increase neurotrophic activity after CNS trauma based on the recently obtained information on pharmacological and molecular control of the expression of these genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594213     DOI: 10.1089/neu.1995.12.853

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  35 in total

1.  FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice.

Authors:  Shinichi Yoshimura; Tetsuyuki Teramoto; Michael J Whalen; Michael C Irizarry; Yasushi Takagi; Jianhua Qiu; Jun Harada; Christian Waeber; Xandra O Breakefield; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 2.  Injury and repair in the neurovascular unit.

Authors:  Changhong Xing; Kazuhide Hayakawa; Josephine Lok; Ken Arai; Eng H Lo
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

3.  Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.

Authors:  Claudia Di Serio; Andrea Cozzi; Ilaria Angeli; Laura Doria; Isabella Micucci; Silvia Pellerito; Patrizia Mirone; Giulio Masotti; Flavio Moroni; Francesca Tarantini
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

4.  Biocompatibility of a coacervate-based controlled release system for protein delivery to the injured spinal cord.

Authors:  Britta M Rauck; Tabitha L Novosat; Martin Oudega; Yadong Wang
Journal:  Acta Biomater       Date:  2014-10-08       Impact factor: 8.947

5.  Sonic Hedgehog Protein : A Novel Approach to the Treatment of Neurodegenerative Disorders?

Authors:  K Pang; T D Ingolia
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

6.  High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter.

Authors:  Kazuhide Hayakawa; Nobukazu Miyamoto; Ji Hae Seo; Loc-Duyen D Pham; Kyu-Won Kim; Eng H Lo; Ken Arai
Journal:  J Neurochem       Date:  2012-12-28       Impact factor: 5.372

7.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury.

Authors:  Antonio Chiaretti; Marco Piastra; Giancarlo Polidori; Concezio Di Rocco; Elena Caresta; Alessia Antonelli; Tiziana Amendola; Luigi Aloe
Journal:  Intensive Care Med       Date:  2003-07-05       Impact factor: 17.440

9.  Neural stem-like cells derived from human amnion tissue are effective in treating traumatic brain injury in rat.

Authors:  Zhong-Jie Yan; Peng Zhang; Yu-Qin Hu; Hong-Tian Zhang; Sun-Quan Hong; Hong-Long Zhou; Mao-Ying Zhang; Ru-Xiang Xu
Journal:  Neurochem Res       Date:  2013-03-10       Impact factor: 3.996

10.  Safety of human neural stem cell transplantation in chronic spinal cord injury.

Authors:  Katja M Piltti; Desiree L Salazar; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.